These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26768366)

  • 21. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
    Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
    Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
    Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
    Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-132 regulates osteogenic differentiation via downregulating Sirtuin1 in a peroxisome proliferator-activated receptor β/δ-dependent manner.
    Gong K; Qu B; Liao D; Liu D; Wang C; Zhou J; Pan X
    Biochem Biophys Res Commun; 2016 Sep; 478(1):260-267. PubMed ID: 27422605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel in vitro model for the assessment of postnatal myonuclear accretion.
    Kneppers A; Verdijk L; de Theije C; Corten M; Gielen E; van Loon L; Schols A; Langen R
    Skelet Muscle; 2018 Feb; 8(1):4. PubMed ID: 29444710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of PPARβ/δ adversely affects satellite cells and reduces postnatal myogenesis.
    Chandrashekar P; Manickam R; Ge X; Bonala S; McFarlane C; Sharma M; Wahli W; Kambadur R
    Am J Physiol Endocrinol Metab; 2015 Jul; 309(2):E122-31. PubMed ID: 25921579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
    Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
    Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PPARβ/δ Agonist GW0742 Induces Early Neuronal Maturation of Cortical Post-Mitotic Neurons: Role of PPARβ/δ in Neuronal Maturation.
    Benedetti E; Di Loreto S; D'Angelo B; Cristiano L; d'Angelo M; Antonosante A; Fidoamore A; Golini R; Cinque B; Cifone MG; Ippoliti R; Giordano A; Cimini A
    J Cell Physiol; 2016 Mar; 231(3):597-606. PubMed ID: 26206209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Lipoic acid up-regulates expression of peroxisome proliferator-activated receptor β in skeletal muscle: involvement of the JNK signaling pathway.
    Rousseau AS; Sibille B; Murdaca J; Mothe-Satney I; Grimaldi PA; Neels JG
    FASEB J; 2016 Mar; 30(3):1287-99. PubMed ID: 26655383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent Regulation of Myotube Formation and Gene Expression by E2 and EPA during In-Vitro Differentiation of C2C12 Myoblasts.
    Lacham-Kaplan O; Camera DM; Hawley JA
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PPARβ/δ agonist GW0742 modulates signaling pathways associated with cardiac myocyte growth via a non-genomic redox mechanism.
    Galatou E; Kelly T; Lazou A
    Mol Cell Biochem; 2014 Oct; 395(1-2):145-54. PubMed ID: 24939361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway.
    Chen SJ; Yue J; Zhang JX; Jiang M; Hu TQ; Leng WD; Xiang L; Li XY; Zhang L; Zheng F; Yuan Y; Guo LY; Pan YM; Yan YW; Wang JN; Chen SY; Tang JM
    Stem Cell Res Ther; 2019 Feb; 10(1):70. PubMed ID: 30819239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta.
    Nadra K; Anghel SI; Joye E; Tan NS; Basu-Modak S; Trono D; Wahli W; Desvergne B
    Mol Cell Biol; 2006 Apr; 26(8):3266-81. PubMed ID: 16581799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Map4k4 as a novel suppressor of skeletal muscle differentiation.
    Wang M; Amano SU; Flach RJ; Chawla A; Aouadi M; Czech MP
    Mol Cell Biol; 2013 Feb; 33(4):678-87. PubMed ID: 23207904
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Eun SY; Chung CH; Cheon YH; Park GD; Lee CH; Kim JY; Lee MS
    Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38785149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inverse agonist DG172 triggers a PPARβ/δ-independent myeloid lineage shift and promotes GM-CSF/IL-4-induced dendritic cell differentiation.
    Lieber S; Scheer F; Finkernagel F; Meissner W; Giehl G; Brendel C; Diederich WE; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2015 Feb; 87(2):162-73. PubMed ID: 25398837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
    Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
    Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5.
    Romero M; Jiménez R; Toral M; León-Gómez E; Gómez-Gúzman M; Sánchez M; Zarzuelo MJ; Rodríguez-Gómez I; Rath G; Tamargo J; Pérez-Vizcaíno F; Dessy C; Duarte J
    J Pharmacol Exp Ther; 2016 Jul; 358(1):151-63. PubMed ID: 27189971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.